Answer:
Information on cases of myocarditis and pericarditis occurring after mRNA COVID-19 vaccination, particularly in adolescents and young adults.
Information on the efficacy of the Pfizer-BioNTech COVID-19 vaccine in adolescents ages 12–15 years in patient counseling.
Updated data on local and systemic symptoms following vaccination with an mRNA COVID-19 vaccines in patient counseling section.
Clarification in contraindications and precautions and Appendix B of guidance for people with a history of an immediate allergic reaction to a vaccine or injectable therapy that contains a component also contained in a COVID-19 vaccine.
Updated list of ingredients in COVID-19 vaccines (i.e., lack of metals) in Appendix C.
Correction of footnote numbering.
Explanation:
#Carry on learning
